Curbstone Financial Management Corp’s GSK GSK Stock Holding History

Curbstone Financial Management Corp’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-7,261	Closed	-$400K	–	207
2021 Q4	$400K	Buy	+7,261	New	+$378K	0.07%	203
2020 Q1	–	Sell	-7,443	Closed	-$437K	–	163
2019 Q4	$437K	Buy	+7,443	New	+$414K	0.1%	172
2017 Q3	–	Sell	-3,744	Closed	-$202K	–	163
2017 Q2	$202K	Sell	3,744 -1,520	-29%	-$81K	0.12%	160
2017 Q1	$277K	Sell	5,264 -220	-4%	-$11.2K	0.17%	137
2016 Q4	$264K	Sell	5,484 -5,713	-51%	-$282K	0.17%	137
2016 Q3	$604K	Buy	11,197 +80	+0.7%	+$4.39K	0.19%	125
2016 Q2	$602K	Buy	11,117 +3,040	+38%	+$160K	0.2%	121
2016 Q1	$409K	Sell	8,077 -808	-9%	-$40.2K	0.14%	153
2015 Q4	$448K	Buy	+8,885	New	+$453K	0.15%	138
2015 Q2	–	Sell	-3,480	Closed	-$201K	–	167
2015 Q1	$201K	Buy	+3,480	New	+$200K	0.14%	158

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Curbstone Financial Management Corp's GSK Position: Q1 2022 in Review

Curbstone Financial Management Corp sold out of GSK (GSK) in Q1 2022, closing a stake of 7,261 shares — an estimated $400K sold.

Curbstone Financial Management Corp first reported a position in GSK in Q1 2015 and held it in 10 quarters. The position peaked at $604K in Q3 2016. 929 funds tracked by Wall St. Rank hold GSK as of Q1 2022.

Curbstone Financial Management Corp reported no remaining GSK position as of Q1 2022 after selling out during the quarter.
Curbstone Financial Management Corp sold 7,261 GSK shares in Q1 2022, an estimated $400K.
Curbstone Financial Management Corp first reported a position in GSK in Q1 2015 and held it in 10 quarters.
Curbstone Financial Management Corp's GSK position peaked at $604K in Q3 2016.
929 funds tracked by Wall St. Rank held GSK as of Q1 2022.

Based on Curbstone Financial Management Corp's 13F filing for Q1 2022, filed 18 Apr 2022.